|
| | 6-CARBOXY-2,4-DIHYDROXYPYRIMIDINE MONOSODIUM SALT Basic information |
| Product Name: | 6-CARBOXY-2,4-DIHYDROXYPYRIMIDINE MONOSODIUM SALT | | Synonyms: | 6-CARBOXY-2,4-DIHYDROXYPYRIMIDINE MONOSODIUM SALT;URACIL-6-CARBOXYLIC ACID MONOSODIUM SALT;OROTIC ACID MONOSODIUM SALT;OROTIC ACID, NA SALT;4-pyrimidinecarboxylicacid,1,2,3,6-tetrahydro-2,6-dioxo-,sodiumsalt,hydr;ate(1:1:1);monosodiumorolatehydrate;oroticacid,sodiumsalt,hydrate(1:1:1) | | CAS: | 154-85-8 | | MF: | C5H5N2NaO4 | | MW: | 180.09 | | EINECS: | 205-834-0 | | Product Categories: | | | Mol File: | 154-85-8.mol |  |
| | 6-CARBOXY-2,4-DIHYDROXYPYRIMIDINE MONOSODIUM SALT Chemical Properties |
| LogP | -0.928 (est) | | CAS DataBase Reference | 154-85-8 |
| Safety Statements | 24/25 | | WGK Germany | 3 | | RTECS | RM3201700 | | HS Code | 29335990 |
| | 6-CARBOXY-2,4-DIHYDROXYPYRIMIDINE MONOSODIUM SALT Usage And Synthesis |
| Chemical Properties | White powder | | Uses | Orotic Acid Monosodium Salt is used in the formation of a complex with lanthanium(III) which displats cytotoxic activity on different tumor cell lines.Also, it is the unlabeled form of Orotic Acid-15N2 Monosodium Salt (O691517), which is an intermediate used in the synthesis of Orotic Acid-15N2 Monohydrate (O691504), which is a labeled analogue of Orotic Acid Monohydrade (O691500), which is used in the preparation of therapeutic agents for chronic obstructive pulmonary disease (COPD) treatment. | | Definition | ChEBI: An organic sodium salt comprising equal numbers of sodium and orotate ions. |
| | 6-CARBOXY-2,4-DIHYDROXYPYRIMIDINE MONOSODIUM SALT Preparation Products And Raw materials |
|
